🇺🇸 FDA
Patent

US 11780821

Inhibitors of fibroblast activation protein

granted A61PA61P3/04A61P3/10

Quick answer

US patent 11780821 (Inhibitors of fibroblast activation protein) held by PRAXIS BIOTECH LLC expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PRAXIS BIOTECH LLC
Grant date
Tue Oct 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P3/04, A61P3/10, A61P35/00